These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2900584)

  • 1. [Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study].
    Bayerdörffer E; Pirlet T; Sommer A; Kasper G; Ottenjann R
    Z Gastroenterol; 1988 Mar; 26(3):155-9. PubMed ID: 2900584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].
    Bayerdörffer E; Kasper G; Pirlet T; Sommer A; Ottenjann R
    Dtsch Med Wochenschr; 1987 Sep; 112(37):1407-11. PubMed ID: 3304929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acid inhibition on Campylobacter pylori.
    Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
    Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric metaplasia and Campylobacter pylori in duodenal ulcer disease: an ultrastructural analysis.
    Malfertheiner P; Bode G; Stanescu A; Ditschuneit H
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):71B-74B. PubMed ID: 2744326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
    Pan S; Liao CH
    Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic, bacteriological and clinical aspects on the use of doxycycline in patients with active duodenal ulcer associated with Campylobacter pylori.
    Unge P; Gnarpe H
    Scand J Infect Dis Suppl; 1988; 53():70-3. PubMed ID: 3166544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
    Schütze K; Hentschel E
    Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.
    Ho J; Hui WM; Ng I; Lam SK
    Aliment Pharmacol Ther; 1989 Jun; 3(3):315-20. PubMed ID: 2577695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
    Avsar E; Kalayci C; Tözün N; Lawrence R; Kiziltas S; Gültekin O; Ulusoy NB
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):449-52. PubMed ID: 8804873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study].
    Ciaco A; Papi C; Capurso L
    Minerva Gastroenterol Dietol; 1992; 38(3):153-9. PubMed ID: 1363719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
    Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of the anti-Helicobacter therapy on the life quality of patients with duodenal ulcers].
    Guseĭnzade MG
    Eksp Klin Gastroenterol; 2005; (5):22-7. PubMed ID: 16518910
    [No Abstract]   [Full Text] [Related]  

  • 14. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
    Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine: a pilot study in Japan.
    Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Iser JH; Buttigieg RJ; Iseli A
    Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.